177 related articles for article (PubMed ID: 11460393)
1. [New guidelines in hypertension. What is relevant for general practice?].
Zidek W
MMW Fortschr Med; 2001 May; 143(22):22-5. PubMed ID: 11460393
[TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
4. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
[TBL] [Abstract][Full Text] [Related]
5. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
[TBL] [Abstract][Full Text] [Related]
6. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
7. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
8. [Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice?].
Hanon O; Anagnostopoulos K; Franconi G; Amah G; Safar M; Girerd X
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):953-7. PubMed ID: 10989736
[TBL] [Abstract][Full Text] [Related]
9. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
Hanon O; Hoguin JC; Girerd X
Arch Mal Coeur Vaiss; 2003; 96(7-8):744-7. PubMed ID: 12945215
[TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
11. [New therapeutic recommendations. Lowering blood pressure--but evidence-based, please].
Dominiak P
MMW Fortschr Med; 1999 Nov; 141(46):43-4. PubMed ID: 10795145
[No Abstract] [Full Text] [Related]
12. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
14. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
15. Lack of control of high blood pressure and treatment recommendations in Canada.
Khan N; Chockalingam A; Campbell NR
Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
[TBL] [Abstract][Full Text] [Related]
16. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad.
Ahmed N; Abdul Khaliq M; Shah SH; Anwar W
J Ayub Med Coll Abbottabad; 2008; 20(2):66-9. PubMed ID: 19385461
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
Varis J; Savola H; Vesalainen R; Kantola I
Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
[TBL] [Abstract][Full Text] [Related]
18. Total cardiovascular risk: a new treatment concept.
Mancia G
J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
[TBL] [Abstract][Full Text] [Related]
19. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
